Sponsor Pipeline

Zhejiang University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
136
Active Trials
77
Recruiting
5
Phase 3
10
Disease Areas
9
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-09 NCT07010523
Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced…
Sponsor changed: Zhejiang University -> First Affiliated Hospital of Zhejiang University
2026-08-09 NCT06572813
Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer
Sponsor changed: Zhejiang University -> First Affiliated Hospital of Zhejiang University
2026-08-09 NCT06503497
A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic…
overall status: Recruiting → Unknown
2026-08-04 NCT07263295
Evaluation of Diaphragmatic Function After Interscalene Block With Liposomal Bupivacaine
Recruitment opened
2026-08-04 NCT07263295
Evaluation of Diaphragmatic Function After Interscalene Block With Liposomal Bupivacaine
date change Primary completion moved earlier: 2026-09-20 -> 2026-08-20
2026-08-04 NCT07263295
Evaluation of Diaphragmatic Function After Interscalene Block With Liposomal Bupivacaine
date change Completion moved earlier: 2026-12-20 -> 2026-08-25
2026-08-02 NCT06423274
Comparing Artificial Intelligence for Assisted Diagnosis of Diabetic Retinopathy
overall status: Not Yet Recruiting → Unknown
2026-07-19 NCT06859840
LEAF (Liver Tumor dEtection And classiFication AI)
Primary endpoint(s) modified
2026-07-19 NCT06859840
LEAF (Liver Tumor dEtection And classiFication AI)
Enrollment increased: 1500 -> 2500 participants
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-14 NCT07766668 Dentate-Targeted Temporal Interference Stimulation for Post-Stroke Dysphagia Not Yet Recruiting
2026-07-30 NCT07736612 A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced… Phase 1/2 Not Yet Recruiting
2026-07-28 NCT07729917 Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 4
1
Phase 3
5
Phase 2
19
Phase 1/2
8
Phase 1
13
Early Phase 1
35
Not specified
55
Active Trials — top 25 of 136
NCT IDTitleConditionStatus
Phase 4
NCT07049094 The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative… Brain Tumor Adult Recruiting
Phase 3
NCT05813015 Study of Comparing of With and Without Sequential Therapy of S-1 Locally Advanced Gastric Adenocarcinoma Recruiting
NCT06172361 Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With… Polymyalgia Rheumatica Recruiting
NCT05593458 Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For… Locally Advanced Gastric Carcinoma Recruiting
NCT05699746 CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD Colorectal Cancer Not Yet Recruiting
NCT06580288 Effect of Finerenone in IgA Nephropathy IgA Nephropathy Not Yet Recruiting
Phase 2
NCT05837052 A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy… Unresectable Lung Non-Small Cell Carcinoma Recruiting
NCT07012772 COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde… Choledocholithiasis With Cholecystitis With Obstruction Recruiting
NCT07051980 Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for… Choledocholithiasis With Cholecystitis With Obstruction Recruiting
NCT06770439 IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer Advanced Pancreatic Cancers Recruiting
NCT07257653 The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune… Colorectal Neoplasms Recruiting
NCT07252336 A Multicenter Study of CAR-T Cells in Primary Ph+All ALL Recruiting
NCT07240766 HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D Mutation Borderline Resectable Pancreatic Adenocarcinoma Recruiting
NCT05731726 Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally… pMMR Recruiting
NCT04661020 CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma Large B-Cell Lymphoma (LBCL) Recruiting
NCT07581912 Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally… Colorectal Cancer Recruiting
NCT06770452 HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced… Metastatic Pancreatic Carcinoma Recruiting
NCT06172036 Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab Neoadjuvant Chemotherapy Not Yet Recruiting
NCT06759090 Metronomic Capecitabine with Camrelizumab and Apatinib Mesylate for Treatment of Advanced… Metastatic Pancreatic Carcinoma Not Yet Recruiting
NCT06848920 Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced… Differentiated Thyroid Carcinoma (DTC) Not Yet Recruiting
NCT06962189 The Efficacy and Safety of Sintilimab Plus Chemotherapy in Surgical Conversion for… Non Small Cell Lung Cancer (Stage III) Not Yet Recruiting
NCT06945926 The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly… Cervical Spinal Stenosis Not Yet Recruiting
NCT07199855 Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk… B-Cell Acute Lymphoblastic Leukemia, Adult Active, Not Recruiting
NCT07415525 IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable… Pancreatic Cancer Not Yet Recruiting
NCT07729917 Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An… Bile Duct Carcinoma Not Yet Recruiting
See all 136 active Zhejiang University trials with filters →
Disease Areas
Get alerts when Zhejiang University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free